Although our cohort was too small to make firm conclusions about clinical associations, we noted that 2 of the 3 patients with CD21-lo B cell expansions also had clinical lymphoproliferation and autoimmunity (Figure 3, subjects “e” and “t,” Supplementary Table 1), both reported associations (7, 11–13). This evidence concerns the gene CR2 and Autoimmunity.